Dr. Tyson Karl Lippe, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3001 Bee Caves Rd Ste 220, Rollingwood, TX 78746 Phone: 512-387-3304 Fax: 512-387-3304 |
News Archive
Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the initiation of its first clinical trial to evaluate the Safety and Efficacy of PAZ320 when added to oral agents or Insulin regimen in Patients with Type 2 Diabetes Mellitus.
Treating high blood pressure, high cholesterol, diabetes and other vascular risk factors may help lower the risk of Alzheimer's disease in people who already show signs of declining thinking skills or memory problems. The research is published in the April 13, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers at the McKnight Brain Institute of the University of Florida have initiated a project to treat human brain and other diseases by plundering the secrets of regeneration from creatures with remarkable powers of self-renewal, such as salamanders, newts, starfish and flatworms.
The Wall Street Journal: The four largest for-profit health insurers in the U.S. - Aetna Inc., Humana Inc., UnitedHealth Group Inc., and WellPoint Inc. - "on average denied policies to one out of every seven applicants based on their prior medical history," according to a congressional investigative report released yesterday by Henry Waxman (D-Calif.), chairman of the House Energy and Commerce Committee, and Rep. Bart Stupak (D-Mich.).
› Verified 7 days ago